CStone Pharmaceuticals (HKG:2616)
Hong Kong · Delayed Price · Currency is HKD 8.69
+0.12 (1.40%)
May 7, 2026, 4:08 PM HKT
CStone Pharmaceuticals Employees
CStone Pharmaceuticals had 136 employees as of December 31, 2025. The number of employees increased by 1 or 0.74% compared to the previous year.
Employees
136
Change
1
Growth
0.74%
Revenue / Employee
2.21M HKD
Profits / Employee
-3.58M HKD
Market Cap
13.70B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 136 | 1 | 0.74% |
| Jun 30, 2025 | 131 | - | - |
| Dec 31, 2024 | 135 | -95 | -41.30% |
| Dec 31, 2023 | 230 | -246 | -51.68% |
| Dec 31, 2022 | 476 | -135 | -22.09% |
| Dec 31, 2021 | 611 | 141 | 30.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Shanghai Haohai Biological Technology | 2,110 |
| Zai Lab | 1,784 |
| Keymed Biosciences | 1,625 |
| Everest Medicines | 812 |
| Ascentage Pharma Group International | 767 |
| Alphamab Oncology | 498 |
| CARsgen Therapeutics Holdings | 355 |
| HBM Holdings | 272 |
CStone Pharmaceuticals News
- 17 days ago - CStone Presented Preclinical Data for Three Novel or Differentiated ADCs at AACR 2026, Including CS5007 (EGFR/HER3) - PRNewsWire
- 6 weeks ago - CStone Announces 2025 Annual Results: Accelerated Expansion of Global Commercial Footprint and Efficient Advancement of Innovation Pipeline 2.0 - PRNewsWire
- 6 weeks ago - CStone Updated Clinical Progress and Key Phase I/II Data for CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody) - PRNewsWire
- 2 months ago - CStone Announces MHRA Approval in UK for Sugemalimab in Stage III NSCLC - PRNewsWire
- 2 years ago - CStone Pharmaceuticals Earnings Call Transcript: H1 2023 - Transcripts